When kidney cancer reaches stage IV, also known as renal cell carcinoma stage IV, it means the disease has spread beyond the kidney to other parts of the body. Getting the right diagnostic tests is essential for understanding the extent of the cancer and planning the best treatment approach, which can help improve quality of life even when a cure may not be possible.

Who Should Undergo Diagnostics and When

Diagnostics for renal cell carcinoma stage IV often begin unexpectedly. Many people discover they have kidney cancer not because they felt something was wrong with their kidneys, but because they experienced symptoms elsewhere in their body. Sometimes, the cancer is found accidentally during tests for completely different health concerns.^[5][13][17]

If you notice certain warning signs, it’s important to seek medical attention promptly. These signs include blood appearing in your urine, which is called hematuria and may make your urine look pink, red, or brown. You might also feel persistent pain in your side or lower back that doesn’t seem related to an injury. An unusual lump in your abdomen or flank area—the sides of your body between your hips and ribs—is another reason to contact your doctor. Other symptoms that should prompt you to get checked include unexplained weight loss, fever that comes and goes without an obvious cause, night sweats that drench your clothing or bedding, and ongoing tiredness that doesn’t improve with rest.^[3]

Stage IV renal cell carcinoma means the cancer has advanced beyond the kidney itself. It may have grown outside the tissue surrounding the kidney, called the fascia, or spread into the adrenal gland, which sits on top of the kidney. More commonly at this stage, cancer cells have traveled to distant organs such as the lungs, bones, liver, or brain. These distant cancer spots are called metastases or secondary cancers.^[4][6]

Interestingly, many people with stage IV kidney cancer don’t experience any kidney-related symptoms at all. The pain or discomfort they feel often comes from where the cancer has spread. For example, someone might go to their doctor complaining of severe back or hip pain, thinking it’s an orthopedic problem like arthritis or a herniated disk, only to discover through imaging tests that the pain is caused by cancer that has spread to their bones.^[5][13]

Classic Diagnostic Methods Used to Identify and Stage the Disease

When doctors suspect kidney cancer or need to determine how far it has spread, they use a combination of different tests. Each test provides specific information that helps build a complete picture of your condition.

Physical Examination and Medical History

Your doctor will start by asking detailed questions about your symptoms, when they began, and any changes you’ve noticed in your health. They will also want to know about your medical history, including any risk factors like smoking, high blood pressure, or kidney disease. During the physical exam, your doctor will feel your abdomen to check for lumps or swelling and may look for other signs that cancer has affected your body.^[2]

Blood Tests

Blood tests cannot directly detect kidney cancer, but they provide valuable information about how well your kidneys are functioning and your overall health. These tests measure substances in your blood such as waste products that healthy kidneys would normally remove. Blood tests can also check for anemia, which is a low red blood cell count that sometimes occurs with kidney cancer. Additionally, they can detect abnormal levels of calcium or liver enzymes that might suggest cancer has spread to bones or the liver.^[2]

Urine Tests

A urinalysis examines your urine under a microscope to look for blood cells, which may not be visible to the naked eye. While blood in the urine can have many causes besides cancer, it’s an important finding that needs further investigation when kidney cancer is suspected.^[2]

CT Scan (Computed Tomography)

A CT scan is one of the most important imaging tests for kidney cancer. This test uses X-rays taken from different angles and combines them with computer processing to create detailed cross-sectional images of your body. A CT scan can show the size and location of a kidney tumor, whether it has grown into nearby structures, and whether cancer has spread to lymph nodes or other organs. Often, you’ll receive an injection of a contrast material, also called dye, before the scan to make certain tissues show up more clearly. The CT scan is particularly good at detecting cancer that has spread to the lungs, which is one of the most common sites of metastasis in kidney cancer.^[2][5]

MRI Scan (Magnetic Resonance Imaging)

An MRI scan uses powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues inside your body. MRI is especially useful for examining the kidneys and can provide information about whether cancer has grown into blood vessels, such as the renal vein (the vein that carries blood away from the kidney) or the vena cava (the large vein that returns blood to the heart). Some people receive MRI instead of CT if they have kidney problems that make contrast dye used in CT scans risky, or if more detailed images of certain areas are needed.^[2]

Ultrasound

An ultrasound uses sound waves to create images of your kidneys and surrounding structures. It’s often one of the first imaging tests performed because it’s safe, painless, and doesn’t use radiation. Ultrasound can help distinguish between a solid tumor and a fluid-filled cyst, which is usually not cancerous. However, ultrasound doesn’t provide as much detail as CT or MRI scans, so additional imaging is typically needed.^[2]

Bone Scan

If doctors suspect that kidney cancer may have spread to your bones—for example, if you’re experiencing bone pain—they may order a bone scan. During this test, a small amount of radioactive material is injected into your vein. This material collects in areas of bone where cancer cells are present, creating “hot spots” on the scan images. Bone metastases are common in advanced kidney cancer and can cause significant pain.^[5][13]

Biopsy

A biopsy involves removing a small sample of tissue so it can be examined under a microscope. For kidney cancer, biopsies are not always necessary because imaging tests can often provide enough information. However, a biopsy may be performed to confirm the diagnosis, determine what type of kidney cancer you have, or check whether a spot in another organ is a metastasis from the kidney cancer. During a kidney biopsy, a thin needle is inserted through your skin into the tumor, usually guided by ultrasound or CT imaging. The tissue sample is then analyzed by a pathologist, a doctor who specializes in diagnosing diseases by examining tissue samples.^[2][13]

For stage IV disease, biopsies are sometimes performed on metastatic sites rather than the kidney tumor itself. For instance, if imaging shows spots in your lungs or a lesion in your bones, a biopsy of those areas can confirm whether they contain kidney cancer cells.^[5]

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial—a research study testing new treatments—you’ll likely need additional or repeated diagnostic tests. Clinical trials have strict criteria about who can participate, and these tests help researchers ensure that the trial is appropriate for you and that they can accurately measure how well the treatment works.

Comprehensive Imaging Studies

Clinical trials often require recent and detailed imaging of all areas where cancer is present. This creates a baseline that researchers can use to compare later images and see if the treatment is shrinking tumors or preventing them from growing. You may need a complete set of CT scans covering your chest, abdomen, and pelvis, even if previous scans focused only on specific areas. Some trials require MRI scans of certain organs or bone scans if there’s any possibility of bone involvement.^[2]

Tissue Analysis and Biomarkers

Many modern clinical trials test treatments that target specific features of cancer cells. To determine if you’re a good candidate, researchers need to analyze your tumor tissue for particular biomarkers—biological characteristics that indicate how your cancer might respond to treatment. This might involve performing a new biopsy or testing tissue from a previous surgery or biopsy. The pathologist looks for specific proteins, genes, or other molecules in the cancer cells.^[2]

For example, some trials focus on cancers with specific genetic mutations or protein expressions. The tissue analysis helps match you with trials testing treatments most likely to benefit your particular type of kidney cancer. This approach is sometimes called precision medicine because it aims to personalize treatment based on the unique characteristics of your cancer.

Organ Function Tests

Clinical trials need to ensure that participants are healthy enough to tolerate the experimental treatment and that their organs can process the medications safely. You’ll typically need blood tests to check your kidney function, liver function, and blood cell counts. These tests measure how well your remaining kidney is working if one has been removed, whether your liver can process medications properly, and whether your bone marrow is producing enough blood cells.^[2]

Some trials have specific requirements about kidney function. For instance, they might require that your creatinine level—a waste product that kidneys normally remove—stays below a certain level. If kidney function is too impaired, you might not be able to safely participate in that particular trial, though other trials with different criteria might still be options.

Performance Status Assessment

Researchers also need to know how the cancer is affecting your ability to carry out daily activities. They use standardized scales to rate your performance status, which describes how active you are and how much assistance you need. Your doctor might ask whether you can work, take care of yourself, walk around, or spend most of your time in bed. This information helps determine if you meet the trial’s eligibility criteria and also serves as a baseline to see if the treatment improves your functional abilities.^[2]

Assessment of Disease Extent

Clinical trials often use classification systems to categorize participants based on how advanced their cancer is and their overall prognosis. One such system is the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) classification, which considers factors like time from diagnosis to treatment, blood test results, and performance status. This classification helps researchers group participants with similar disease characteristics, making it easier to interpret study results.^[10]

These prognostic factors help predict survival and treatment response. Trials may specifically seek participants with favorable, intermediate, or poor prognosis to test whether new treatments work better in certain groups of patients.